SONOMA PHARMACEUTICALS INC

Sonoma Pharmaceuticals Q1 earnings turn positive with FDA‑cleared dermatology products, growing margins, and a global distribution push – a strong outlook for investors.

Sonoma Pharmaceuticals focuses on innovative dermatology and advanced wound care, navigating market volatility with a global reach and patient‑centric R&D.

Sonoma Pharmaceuticals Inc is a leading player in the dermatological solutions market, poised to leverage its expertise and strategic initiatives to drive growth and innovation in the pharmaceutical industry.